查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790386

美國ATP 檢測市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途和細分市場預測，2025 年至 2033 年

U.S. ATP Assays Market Size, Share & Trends Analysis Report By Type (Luminometric ATP Assays, Enzymatic ATP Assays), By Application (Drug Discovery & Development, Clinical Diagnostics), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國ATP 檢測市場規模與趨勢

預計 2024 年美國ATP 檢測市場價值將達到 11 億美元，到 2033 年複合年成長率將達到約 3.87%。

該市場的主要驅動力在於藥物研發、臨床診斷、環境監測和食品安全應用領域對快速可靠檢測方法日益成長的需求。在藥物研發和臨床研究中，ATP 檢測在細胞活力和細胞毒性測試中發揮關鍵作用；而在環境檢測和食品品管， ATP 檢測則支援污染檢測和衛生檢驗。這些領域對高效能即時分析日益成長的需求，持續推動著基於發光的自動化 ATP 平台的普及。

此外，不斷成長的檢測樣本量推動了更先進的 ATP 檢測系統的採用，這些系統支援更快、更有效率的處理。改進的樣本製備、測量和管理使實驗室能夠更有效率地工作並減少延誤。這些變化使藥物檢測和污染檢測等對時間和準確性至關重要的領域受益。 2024 年 12 月，Hygena 收購了 Nexcor Food Safety Technologies Inc.，增強了其 ATP 和環境監測產品線，並滿足了對快速、可靠檢測解決方案日益成長的需求。

此外，美國ATP檢測市場正經歷著向整合自動化檢測系統的顯著轉變，尤其是在製藥和食品品管。這些平台旨在透過將快速檢測功能與數位記錄保存和雲端基礎分析相結合，簡化污染監測和法規遵循。對標準化、可追溯和高通量工作流程日益成長的需求，正在推動各個細分市場的採用。這種轉變與強調即時數據、業務效率和遵守不斷變化的法規要求的更廣泛趨勢相一致，正在推動美國ATP檢測市場的持續擴張。

此外，醫療保健、食品製造和環境領域對生物安全和品質保證標準的日益重視，也推動了對 ATP 檢測技術的持續投資。實驗室和生產設施越來越注重降低污染風險，並符合美國食品藥物管理局 (FDA) 和美國農業部 (USDA) 等機構制定的監管準則。這推動了 ATP檢測法融入品管框架，尤其是在環境監測和常規篩檢工作流程中。隨著各機構越來越重視合規性和效率，美國ATP 檢測市場預計將受益於快速、準確且可擴展的檢測解決方案的穩定、跨領域需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國ATP 檢測市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國ATP檢測市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章。美國ATP 檢測市場類型、估計與趨勢分析

  • 2024年和2033年的類型市場佔有率
  • 細分儀表板
  • 美國ATP檢測市場展望（按類型）
  • 2021年至2033年市場規模、預測與趨勢分析
    • 發光ATP測定法
    • 酶促ATP測定
    • 生物發光共振能量轉移（BRET）ATP測定
    • 基於細胞的ATP測定
    • 其他

第5章美國ATP 檢測市場：應用、估算與趨勢分析

  • 2024 年和 2033 年應用市場佔有率
  • 細分儀表板
  • 美國ATP 檢測市場：應用前景
  • 2021年至2033年市場規模、預測與趨勢分析
    • 藥物研發
    • 臨床診斷
    • 環境檢查
    • 食品安全與品質檢驗
    • 其他

第6章美國ATP 檢測市場：依最終用途的估算與趨勢分析

  • 2024年和2033年的最終用途市場佔有率
  • 細分儀表板
  • 美國ATP檢測市場：最終用途展望
  • 2021年至2033年市場規模、預測與趨勢分析
    • 製藥和生物技術公司
    • 學術研究機構
    • 醫院和診斷實驗室

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 2024年主要企業市場佔有率分析
    • Thermo Fisher Scientific
    • Promega Corporation
    • PerkinElmer Inc.
    • Becton, Dickinson and Company（BD）
    • Lonza Group Ltd.
    • Danaher Corporation
    • Abcam plc
    • Quest Diagnostics Incorporated
    • Biomerieux SA
    • 3M Company
Product Code: GVR-4-68040-682-7

U.S. ATP Assays Market Size & Trends:

The U.S. ATP assays market size was estimated at USD 1.10 billion in 2024 and is projected to register a CAGR of around 3.87% through 2033. The market is primarily driven by increasing demand for rapid, reliable testing methods across drug discovery, clinical diagnostics, environmental monitoring, and food safety applications. In drug development and clinical research, ATP assays play a key role in cell viability and cytotoxicity studies, while their use in environmental testing and food quality control supports contamination detection and hygiene verification. The growing need for high throughput, real time analysis across these sectors continues to support adoption of automated, luminescence based ATP platforms.

In addition, the rising number of samples being tested has led to the adoption of more advanced ATP assay systems that support faster and more efficient processing. Improvements in preparing, measuring, and managing samples have helped laboratories work more effectively and reduce delays. These changes benefit areas such as drug testing and contamination detection, where time and accuracy matter. In December 2024, Hygiena acquired Nexcor Food Safety Technologies Inc., strengthening its range of ATP and environmental monitoring products and supporting the growing demand for quick, reliable testing solutions.

Moreover, the U.S. ATP Assays market is witnessing a notable shift toward integrated and automated detection systems, particularly in pharmaceutical manufacturing and food quality control. These platforms are designed to streamline contamination monitoring and regulatory compliance by combining rapid testing capabilities with digital record-keeping and cloud-based analytics. The growing need for standardized, traceable, and high-throughput workflows drives adoption across various sectors. This shift aligns with broader trends emphasizing real-time data, operational efficiency, and adherence to evolving regulatory requirements, reinforcing the continued expansion of the U.S. ATP Assays market.

Furthermore, growing awareness of biosafety and quality assurance standards across healthcare, food production, and environmental sectors supports sustained investment in ATP assay technologies. Laboratories and production facilities are placing increased emphasis on minimizing contamination risks and meeting regulatory guidelines set by agencies such as the FDA and USDA. This has led to greater integration of ATP assays within quality control frameworks, particularly within environmental monitoring and routine screening workflows. With organizations prioritizing compliance and efficiency, the U.S. ATP Assays market is expected to benefit from stable, cross-sector demand for fast, accurate, and scalable testing solutions.

U.S. ATP Assays Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. ATP assays market on the test type,application, and end use:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Luminometric ATP Assays
  • Enzymatic ATP Assays
  • Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
  • Cell-based ATP Assays
  • Others
  • Application Outlook (Revenue, USD Million, 2021- 2033)
  • Drug Discovery and Development
  • Clinical Diagnostics
  • Environmental Testing
  • Food Safety and Quality Testing
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospital and Diagnostics Laboratories

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. ATP Assays market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising emphasis on cell-based research in drug development
      • 3.2.1.2. Increased adoption in food and beverage industry for hygiene monitoring
      • 3.2.1.3. Expansion of biomanufacturing and bioprocess monitoring
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Limited specificity in complex biological samples
      • 3.2.2.2. Availability of alternative assay techniques
  • 3.3. U.S. ATP Assays market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. ATP Assays market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. U.S. ATP Assays market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.4.1. Luminometric ATP Assays
      • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Enzymatic ATP Assays
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.4. Cell-based ATP Assays
      • 4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. ATP Assays market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2024 & 2033
  • 5.2. Segment Dashboard
  • 5.3. U.S. ATP Assays market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. Drug Discovery and Development
      • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Clinical Diagnostics
      • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Environmental Testing
      • 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.4. Food Safety and Quality Testing
      • 5.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. ATP Assays market: End use Estimates & Trend Analysis

  • 6.1. End use Market Share, 2024 & 2033
  • 6.2. Segment Dashboard
  • 6.3. U.S. ATP Assays market by End use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 6.4.1. Pharmaceutical and Biotechnology Companies
      • 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Academic and Research Institutes
      • 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. Hospital and Diagnostics Laboratories
      • 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2024
    • 7.3.4. Thermo Fisher Scientific
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Promega Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. PerkinElmer Inc.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Becton, Dickinson and Company (BD)
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Lonza Group Ltd.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Danaher Corporation
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Abcam plc
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Quest Diagnostics Incorporated
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Biomerieux SA
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. 3M Company
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. ATP assays market, by type, 2021 - 2033 (USD Million)
  • Table 3 U.S. ATP assays market, by application, 2021 - 2033 (USD Million)
  • Table 4 U.S. ATP assays market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in U.S.
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. ATP Assays market: market outlook
  • Fig. 10 U.S. ATP Assays competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. ATP Assays market driver impact
  • Fig. 16 U.S. ATP Assays market restraint impact
  • Fig. 17 U.S. ATP Assays market strategic initiatives analysis
  • Fig. 18 U.S. ATP Assays market: Type movement analysis
  • Fig. 19 U.S. ATP Assays market: Type outlook and key takeaways
  • Fig. 20 Luminometric ATP Assays market estimates and forecast, 2021 - 2033
  • Fig. 21 Enzymatic ATP Assays market estimates and forecast, 2021 - 2033
  • Fig. 22 Bioluminescence Resonance Energy Transfer (BRET) ATP Assays market estimates and forecast, 2021 - 2033
  • Fig. 23 Cell-based ATP Assays market estimates and forecast, 2021 - 2033
  • Fig. 24 Others market estimates and forecast, 2021 - 2033
  • Fig. 25 U.S. ATP Assays market: Application movement Analysis
  • Fig. 26 U.S. ATP Assays market: Application outlook and key takeaways
  • Fig. 27 Drug Discovery and Development market estimates and forecasts, 2021 - 2033
  • Fig. 28 Clinical Diagnostics market estimates and forecasts, 2021 - 2033
  • Fig. 29 Environmental Testing market estimates and forecasts, 2021 - 2033
  • Fig. 30 Food Safety and Quality Testing market estimates and forecasts, 2021 - 2033
  • Fig. 31 Others market estimates and forecasts, 2021 - 2033
  • Fig. 32 U.S. ATP Assays market: End use movement analysis
  • Fig. 33 U.S. ATP Assays market: End use outlook and key takeaways
  • Fig. 34 Pharmaceutical and Biotechnology Companies market estimates and forecasts, 2021 - 2033
  • Fig. 35 Academic and Research Institutes market estimates and forecasts, 2021 - 2033
  • Fig. 36 Hospital and Diagnostics Laboratories market estimates and forecasts, 2021 - 2033
  • Fig. 37 U.S. ATP Assays market share and leading players
  • Fig. 38 U.S. market share and leading players
  • Fig. 39 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 40 Market share of key market players - U.S. ATP Assays market